sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
×Ô¾õÐÔÂѳ²°©¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Éúֳϵͳģ×Ó > ×Ô¾õÐÔÂѳ²°©¶¯ÎïÄ£×Ó

ǰÑÔ

Âѳ²°©(ovarian carcinoma)ÊÇÅ®ÐÔÉúֳϵͳ³£¼ûµÄ¶ñÐÔÖ×Áö£¬Æä·¢²¡ÂÊ¡¢²¡ËÀÂʾù¾Ó¸¾¿Æ¶ñÐÔÖ×ÁöǰÏß¡£ÏÖÔÚ½¨ÉèÂѳ²°©¶¯ÎïÄ£×ÓµÄÒªÁìÓÐ×Ô¾õÐÔµÄÂѳ²Ö×Áö¶¯ÎïÄ£×Ó¡¢ÌåÍâת»¯Âѳ²ÉÏÆ¤Ï¸°ûµÄÒÆÖ²Áö¡¢Ö°©ÎïÓÕ·¢Âѳ²Ö×ÁöÒÔ¼°»ùÒò¹¤³ÌÂѳ²Ö×Áö¶¯ÎïÄ£×Ó¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎÇÝÀࡢСÊó¡¢¶«·½ÌïÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

×Ô¾õÐÔÖ×ÁöÊÇʵÑ鶯ÎïÖÖȺÖÐ×ÔÈ»±¬·¢»òͨ¹ýÒÅ´«ÓýÖÖ×÷Óý¶øÐγɵÄÒ»ÀàÖ×Áö£¬ÌصãÊÇÕâÖÖ¶¯ÎïÄ£×ÓÉú³¤µ½Ò»¶¨ÄêËê±ã×Ô¾õ±¬·¢Âѳ²°©¡£

¡¾Ä£×ÓÌØµã¡¿£º

Äܹ»×Ô¾õ±¬·¢Âѳ²°©µÄ¶¯Îïδ¼¸£¬²î±ðÖÖÀàµÄʵÑ鶯Îï×Ô¾õÂѳ²°©µÄÌØµãÒ²²î±ð¡£

ÇÝÀࣺĸ¼¦ÓÉÓÚ¹ý¶àµÄϵ°³£»á±¬·¢Âѳ²µÄÏÙ°©£¬µ«¶àÒª±¬·¢ÔÚÓÐ2ÄêÒÔÉϲúµ°ÁäµÄĸ¼¦¡£

СÊó£ºÓÐЩƷϵµÄСÊóËæÄêËêµÄÔöÌí¿ÉÒÔ×Ô¾õ±¬·¢Âѳ²Ö×Áö£¬ÕâЩÖ×Áö¿ÉÒÔ·ºÆð²î±ðµÄ×é֯ѧÀàÐÍ£¬Èç¿É·ºÆð¹Ü×´ÏÙÁö¡¢ÏÙ°©¡¢Èé×´ÏåÏÙÁö¡¢¼äƤÁö¡¢¿ÅÁ£Ï¸°ûÁöµÈ¡£ÈçC3HeB/FeºÍC3HeB/DeϵµÄСÊó£¬Óнϸߵļ¸Âʱ¬·¢¿ÅÁ£Ï¸°ûÁöºÍ¹Ü×´ÏÙÁö¡£ÔÚ4~6ÖÜËÇÑøµÄ´¿ÖÖSWR/JºÍSWR/BmСÊó¿É¼û×Ô¾õÐԵĿÅÁ£Ï¸°ûÁö£¬ÓÐʱҪÔÚÍÑÇâÒìÐÛͪµÄÓÕµ¼Ï²ÅÓнϸߵı¬·¢ÂÊ¡£×Ô¾õÐÔµÄÉúֳϸ°ûÐÔÖ×Áö²¢Î´¼¸¼û£¬Óб¨µÀÔÚLT/SvСÊ󣬻ûÌ¥ÁöÓнϸߵı¬·¢ÂÊ¡£

¶«·½ÌïÊó£ºÔÚ¶Ô¶«·½ÌïÊó¾ÙÐÐʵÑ鶯ÎﻯµÄÑо¿ÖУ¬·¢Ã÷ÔÚÒѽ¨ÉèµÄ¶«·½ÌïÊ󹨱ÕȺÖÐÂѳ²°©µÄ×ÔÈ»±¬·¢ÂÊÔÚ³ÉÄê´ÆÐÔ¶¯ÎïÔ¶Ô¶¸ßÓÚÆäËû¶¯Î¾­ÁÙ´²Ó벡ÀíѧÊӲ죬ËüÃÇÓëÈËÀàÏìÓ¦µÄ¼²²¡ÓÐÐí¶àÏà֮ͬ´¦¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

ÓÉÓÚÕâÖÖ×Ô¾õÐÔÖ×ÁöµÄ±¬·¢ÂʵÍ£¬Í¬Ê±ÐèÒª½Ï³¤µÄʱ¼ä£¬Òò¶øÒ»Ñùƽ³£²»ÊÊÊÊÓÃÀ´×öΪÂѳ²Áö·¢²¡»úÖÆµÄÑо¿¡£

 

²Î¿¼ÎÄÏ×£º

1.Òü°®À¼£¬ÖÓ÷£¬Ëï¹ðÇÛ£¬µÈ£®ÂÌɫӫ¹âÂѰױê¼ÇµÄÈËÂѳ²°©ÂãÊóÔ­Î»ÒÆÖ²Ä£×ӵĽ¨É裮ÄÏ·½Ò½¿Æ´óѧѧ±¨£¬2008,28 (3):484-486

2.ãÆÖÒöΣ¬º«·ï¾ê£¬µÔСÁú£¬µÈ£®Âѳ²°©ÂãÊóÒÆÖ²ÁöÄ£×Ó±ÈÕպͿÉÊÓ»¯Ñо¿Ï£Íû£®ÌìÏÂÖÐÎ÷ҽ͎áÔÓÖ¾£¬2012, 7 (7):636-638

3.ÇñÀö骣¬º«·ç¾ê£¬·¶ÏÔ×Å£¬µÈ£®Á½ÖÖÓÕ·¢Fischer344´óÊóÂѳ²°©¶¯ÎïÄ£×Ó½¨ÉèÒªÁìµÄ½ÏÁ¿. ÌìÏÂÖÐÎ÷ҽ͎áÔÓÖ¾£¬2010,5(6):488-490

4.Ò¦µÂÉú£®ÖØ×鷴ת¼²¡¶¾½éµ¼µÄk-Ras/c-MycСÊóÂѳ²°©¶¯ÎïÄ£×ӵĽ¨ÉèºÍÒÖ°©»ùÒòOPCMLµÄ¿Ë¡¼°ÆäÔÚÂѳ²°©ÖеĹ¦Ð§Ñо¿£®¹ãÎ÷Ò½¿Æ´óѧ²©Ê¿Ñ§Î»ÂÛÎÄ£¬2005

5.Àè¾²£¬ÍõÑ©·É£¬ÖÓ÷£®ÕûÌå¿ÉÊÓ»¯Âѳ²°©Ô­Î»¼°×ªÒƶ¯ÎïÄ£×ӵĽ¨É裮¹ã¶«Ò½Ñ§£¬2012, 33 (7):887-889

6.öÄȫУ¬ÃÓÈôÈ». ת»ùÒò¶¯ÎïÔÚÂѳ²Ö×ÁöÑо¿ÖеÄÓ¦Óã®ÍâÑóҽѧ¸¾²ú¿ÆÑ§·Ö²á£¬2003,30 (6):391-393

7.Connolly DC, Bao R, Nikitin AY, el al. Female mice chimeric for expression of the simian virus 40 TAg under control of the MlSilR promoter develop epithelial ovarian cancer, Cancer res 2003, 63 (6): 1389-1397

8.Dutertre M, Couédard L, Xavier F, el al. Ovarian granulosa cell tumors express a functional membrane receptor for anti-Müllerian hormone in transgenic mice. Endocri.nology, 2001, 142 (9):4040-4046

9.Carson K, Macdonald E, Dube M, et al. Generali on of tumors in transgece mice expressing the SV40 T antigen under the control of ovarian-specific promoter 1. J Soc Cynecol lnvestig,2003,10(4):244-250

10.Hoffman RM. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherap. Methods Mol Med,2005, 111 :297-322

11.Kananen K, Markkula M, Rainio E, et al. Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin alpha-subunit promoter/simian virus T-antigen fusion gene: characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines. Mol Endocrinol, 1995,9 (5):616-627

12.Selvakumaran M, Bao R, Crijns AP, el al. Ovarian epithelial cell lineage-specific gene expression using the promoter of a retrovirus-like element. Cancer Res,2001, 61 (4):1291-1295

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Éúֳϵͳģ×Ó > ×Ô¾õÐÔÂѳ²°©¶¯ÎïÄ£×Ó
×Ô¾õÐÔÂѳ²°©¶¯ÎïÄ£×Ó

ǰÑÔ

Âѳ²°©(ovarian carcinoma)ÊÇÅ®ÐÔÉúֳϵͳ³£¼ûµÄ¶ñÐÔÖ×Áö£¬Æä·¢²¡ÂÊ¡¢²¡ËÀÂʾù¾Ó¸¾¿Æ¶ñÐÔÖ×ÁöǰÏß¡£ÏÖÔÚ½¨ÉèÂѳ²°©¶¯ÎïÄ£×ÓµÄÒªÁìÓÐ×Ô¾õÐÔµÄÂѳ²Ö×Áö¶¯ÎïÄ£×Ó¡¢ÌåÍâת»¯Âѳ²ÉÏÆ¤Ï¸°ûµÄÒÆÖ²Áö¡¢Ö°©ÎïÓÕ·¢Âѳ²Ö×ÁöÒÔ¼°»ùÒò¹¤³ÌÂѳ²Ö×Áö¶¯ÎïÄ£×Ó¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯ÎÇÝÀࡢСÊó¡¢¶«·½ÌïÊó

¡¾ÔìÄ£»úÖÆ¡¿£º

×Ô¾õÐÔÖ×ÁöÊÇʵÑ鶯ÎïÖÖȺÖÐ×ÔÈ»±¬·¢»òͨ¹ýÒÅ´«ÓýÖÖ×÷Óý¶øÐγɵÄÒ»ÀàÖ×Áö£¬ÌصãÊÇÕâÖÖ¶¯ÎïÄ£×ÓÉú³¤µ½Ò»¶¨ÄêËê±ã×Ô¾õ±¬·¢Âѳ²°©¡£

¡¾Ä£×ÓÌØµã¡¿£º

Äܹ»×Ô¾õ±¬·¢Âѳ²°©µÄ¶¯Îïδ¼¸£¬²î±ðÖÖÀàµÄʵÑ鶯Îï×Ô¾õÂѳ²°©µÄÌØµãÒ²²î±ð¡£

ÇÝÀࣺĸ¼¦ÓÉÓÚ¹ý¶àµÄϵ°³£»á±¬·¢Âѳ²µÄÏÙ°©£¬µ«¶àÒª±¬·¢ÔÚÓÐ2ÄêÒÔÉϲúµ°ÁäµÄĸ¼¦¡£

СÊó£ºÓÐЩƷϵµÄСÊóËæÄêËêµÄÔöÌí¿ÉÒÔ×Ô¾õ±¬·¢Âѳ²Ö×Áö£¬ÕâЩÖ×Áö¿ÉÒÔ·ºÆð²î±ðµÄ×é֯ѧÀàÐÍ£¬Èç¿É·ºÆð¹Ü×´ÏÙÁö¡¢ÏÙ°©¡¢Èé×´ÏåÏÙÁö¡¢¼äƤÁö¡¢¿ÅÁ£Ï¸°ûÁöµÈ¡£ÈçC3HeB/FeºÍC3HeB/DeϵµÄСÊó£¬Óнϸߵļ¸Âʱ¬·¢¿ÅÁ£Ï¸°ûÁöºÍ¹Ü×´ÏÙÁö¡£ÔÚ4~6ÖÜËÇÑøµÄ´¿ÖÖSWR/JºÍSWR/BmСÊó¿É¼û×Ô¾õÐԵĿÅÁ£Ï¸°ûÁö£¬ÓÐʱҪÔÚÍÑÇâÒìÐÛͪµÄÓÕµ¼Ï²ÅÓнϸߵı¬·¢ÂÊ¡£×Ô¾õÐÔµÄÉúֳϸ°ûÐÔÖ×Áö²¢Î´¼¸¼û£¬Óб¨µÀÔÚLT/SvСÊ󣬻ûÌ¥ÁöÓнϸߵı¬·¢ÂÊ¡£

¶«·½ÌïÊó£ºÔÚ¶Ô¶«·½ÌïÊó¾ÙÐÐʵÑ鶯ÎﻯµÄÑо¿ÖУ¬·¢Ã÷ÔÚÒѽ¨ÉèµÄ¶«·½ÌïÊ󹨱ÕȺÖÐÂѳ²°©µÄ×ÔÈ»±¬·¢ÂÊÔÚ³ÉÄê´ÆÐÔ¶¯ÎïÔ¶Ô¶¸ßÓÚÆäËû¶¯Î¾­ÁÙ´²Ó벡ÀíѧÊӲ죬ËüÃÇÓëÈËÀàÏìÓ¦µÄ¼²²¡ÓÐÐí¶àÏà֮ͬ´¦¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

ÓÉÓÚÕâÖÖ×Ô¾õÐÔÖ×ÁöµÄ±¬·¢ÂʵÍ£¬Í¬Ê±ÐèÒª½Ï³¤µÄʱ¼ä£¬Òò¶øÒ»Ñùƽ³£²»ÊÊÊÊÓÃÀ´×öΪÂѳ²Áö·¢²¡»úÖÆµÄÑо¿¡£

 

²Î¿¼ÎÄÏ×£º

1.Òü°®À¼£¬ÖÓ÷£¬Ëï¹ðÇÛ£¬µÈ£®ÂÌɫӫ¹âÂѰױê¼ÇµÄÈËÂѳ²°©ÂãÊóÔ­Î»ÒÆÖ²Ä£×ӵĽ¨É裮ÄÏ·½Ò½¿Æ´óѧѧ±¨£¬2008,28 (3):484-486

2.ãÆÖÒöΣ¬º«·ï¾ê£¬µÔСÁú£¬µÈ£®Âѳ²°©ÂãÊóÒÆÖ²ÁöÄ£×Ó±ÈÕպͿÉÊÓ»¯Ñо¿Ï£Íû£®ÌìÏÂÖÐÎ÷ҽ͎áÔÓÖ¾£¬2012, 7 (7):636-638

3.ÇñÀö骣¬º«·ç¾ê£¬·¶ÏÔ×Å£¬µÈ£®Á½ÖÖÓÕ·¢Fischer344´óÊóÂѳ²°©¶¯ÎïÄ£×Ó½¨ÉèÒªÁìµÄ½ÏÁ¿. ÌìÏÂÖÐÎ÷ҽ͎áÔÓÖ¾£¬2010,5(6):488-490

4.Ò¦µÂÉú£®ÖØ×鷴ת¼²¡¶¾½éµ¼µÄk-Ras/c-MycСÊóÂѳ²°©¶¯ÎïÄ£×ӵĽ¨ÉèºÍÒÖ°©»ùÒòOPCMLµÄ¿Ë¡¼°ÆäÔÚÂѳ²°©ÖеĹ¦Ð§Ñо¿£®¹ãÎ÷Ò½¿Æ´óѧ²©Ê¿Ñ§Î»ÂÛÎÄ£¬2005

5.Àè¾²£¬ÍõÑ©·É£¬ÖÓ÷£®ÕûÌå¿ÉÊÓ»¯Âѳ²°©Ô­Î»¼°×ªÒƶ¯ÎïÄ£×ӵĽ¨É裮¹ã¶«Ò½Ñ§£¬2012, 33 (7):887-889

6.öÄȫУ¬ÃÓÈôÈ». ת»ùÒò¶¯ÎïÔÚÂѳ²Ö×ÁöÑо¿ÖеÄÓ¦Óã®ÍâÑóҽѧ¸¾²ú¿ÆÑ§·Ö²á£¬2003,30 (6):391-393

7.Connolly DC, Bao R, Nikitin AY, el al. Female mice chimeric for expression of the simian virus 40 TAg under control of the MlSilR promoter develop epithelial ovarian cancer, Cancer res 2003, 63 (6): 1389-1397

8.Dutertre M, Couédard L, Xavier F, el al. Ovarian granulosa cell tumors express a functional membrane receptor for anti-Müllerian hormone in transgenic mice. Endocri.nology, 2001, 142 (9):4040-4046

9.Carson K, Macdonald E, Dube M, et al. Generali on of tumors in transgece mice expressing the SV40 T antigen under the control of ovarian-specific promoter 1. J Soc Cynecol lnvestig,2003,10(4):244-250

10.Hoffman RM. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherap. Methods Mol Med,2005, 111 :297-322

11.Kananen K, Markkula M, Rainio E, et al. Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin alpha-subunit promoter/simian virus T-antigen fusion gene: characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines. Mol Endocrinol, 1995,9 (5):616-627

12.Selvakumaran M, Bao R, Crijns AP, el al. Ovarian epithelial cell lineage-specific gene expression using the promoter of a retrovirus-like element. Cancer Res,2001, 61 (4):1291-1295

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿